Verve Therapeutics, Inc. - COM (VERV)

Q3 2024 13F Holders as of 9/30/2024

Type / Class
Equity / COM
Number of holders
168
Total Shares
75.2M
Shares change
-1.45M
Total reported value, excl. options
$364M
Value change
-$7.26M
Put/Call ratio
2.47
Number of buys
89
Number of sells
-68
Price
$4.84
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.